Feasibility analysis of coronavirus disease 2019 co-treated by Zedoary Turmeric Oil Injection

VernacularTitle: 莪术油注射液协同治疗新型冠状病毒肺炎(COVID-19)可行性浅析
Author: Cheng-Xi JIANG ¹
Author Information

1. College of Pharmaceutical Sciences, Wenzhou Medical University
Publication Type:Journal Article
Keywords: COVID-19; Pulmonary fibrosis; SARS-CoV-2; Zedoary turmeric oil; Zedoary Turmeric Oil Injection
From: Chinese Traditional and Herbal Drugs 2020;51(11):3062-3069
CountryChina
Language:Chinese
Abstract: Because of no specific drug for the treatment of coronavirus disease 2019 (COVID-19), a number of treatment plans for COVID-19 had been released by national medical treatment authorities. The efficacy of zedoary turmeric oil and its preparation for antiviral and pulmonary fibrosis treatment had been confirmed by many basic studies and clinical applications. It was speculated that Zedoary Turmeric Oil Injection could be used in the clinical diagnose and treatment of COVID-19, especially in the treatment of pulmonary fibrosis caused by pulmonary interstitial changes, antidiarrheal and fever. In addition, the compatibility of Zedoary Turmeric Oil Injection with other antiviral and antibiotic drugs suggested that it could be used to reduce drug-induced liver injury in the treatment of COVID-19 patients, and improve the therapeutic effect, which provided a theoretical basis for the scientific use of zedoary turmeric oil and its injection in the treatment of COVID-19.